Il Dong Pharmaceutical Co Ltd (249420) — Financial Flexibility Index
Il Dong Pharmaceutical Co Ltd (249420) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of ₩17.26 Billion (operating CF ₩11.28 Billion minus capex ₩5.97 Billion) represents 0% of total liabilities (₩347.04 Billion). Check Il Dong Pharmaceutical Co Ltd (249420) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Il Dong Pharmaceutical Co Ltd Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Il Dong Pharmaceutical Co Ltd across 9 annual periods. See 249420 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Il Dong Pharmaceutical Co Ltd (2016–2024)
Year-by-year free cash flow to debt coverage for Il Dong Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market cap of Il Dong Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.10x | ₩42.35 Billion | ₩28.29 Billion | ₩429.99 Billion | ▲ +333.5% |
| 2023 | -0.04x | ₩-18.43 Billion | ₩-36.62 Billion | ₩437.00 Billion | ▲ +53.7% |
| 2022 | -0.09x | ₩-41.67 Billion | ₩-53.54 Billion | ₩457.59 Billion | ▼ -1631.9% |
| 2021 | 0.01x | ₩3.26 Billion | ₩-11.37 Billion | ₩548.39 Billion | ▼ -93.8% |
| 2020 | 0.10x | ₩33.72 Billion | ₩19.37 Billion | ₩350.73 Billion | ▼ -35.3% |
| 2019 | 0.15x | ₩53.43 Billion | ₩41.37 Billion | ₩359.83 Billion | ▼ -47.7% |
| 2018 | 0.28x | ₩81.73 Billion | ₩66.65 Billion | ₩287.84 Billion | ▼ -12.2% |
| 2017 | 0.32x | ₩90.45 Billion | ₩73.72 Billion | ₩279.55 Billion | ▲ +51.5% |
| 2016 | 0.21x | ₩60.20 Billion | ₩45.98 Billion | ₩281.94 Billion | — |